Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Ugeskrift for Laeger
|
August 28, 1989
[Psychological diagnosis of mental disorders. Problems concerning the validity and reproducibility]
J Olesen, T G Bolwig, F Gjerris, et al.
Ugeskrift for Laeger
|
November 19, 1971
[Levodopa and Parkinsonism. A double-blind study]
H Pakkenberg, E Dupont, B Garde, et al.
European Journal of Clinical Pharmacology
|
August 1, 1980
Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease
M L Friis, T Johnsen, N E Larsen, et al.
Psychopharmacology
|
November 24, 1976
High-dose treatment of rats with perphenazine enanthate
R Fog, H Pakkenberg, P Juul, et al.
European Journal of Clinical Pharmacology
|
May 21, 1979
Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease
M L Friis, U Grøn, N E Larsen, et al.
Ugeskrift for Laeger
|
November 11, 1974
[The concentrations of arsenic, manganese and selenium in organs from normal and uremic persons determined by activation analysis]
N A Larsen, B Nielsen, H Pakkenberg, et al.
Neurotoxicology and Teratology
|
April 7, 1999
MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study
M Mikkelsen, A Møller, L H Jensen, et al.
The New England Journal of Medicine
|
May 30, 1985
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
R S Burns, P A LeWitt, M H Ebert, et al.
Journal of Neuroscience Methods
|
February 1, 1990
An efficient method for estimating the total number of neurons in rat brain cortex
L Korbo, B Pakkenberg, O Ladefoged, et al.
Acta Neurologica Scandinavica
|
January 1, 1974
RNA treatment of dementia. A double-blind study
S Munch-Petersen, H Pakkenberg, H Kornerup, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Ugeskrift for Laeger
|
August 28, 1989
[Psychological diagnosis of mental disorders. Problems concerning the validity and reproducibility]
J Olesen, T G Bolwig, F Gjerris, et al.
Ugeskrift for Laeger
|
November 19, 1971
[Levodopa and Parkinsonism. A double-blind study]
H Pakkenberg, E Dupont, B Garde, et al.
European Journal of Clinical Pharmacology
|
August 1, 1980
Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease
M L Friis, T Johnsen, N E Larsen, et al.
Psychopharmacology
|
November 24, 1976
High-dose treatment of rats with perphenazine enanthate
R Fog, H Pakkenberg, P Juul, et al.
European Journal of Clinical Pharmacology
|
May 21, 1979
Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease
M L Friis, U Grøn, N E Larsen, et al.
Ugeskrift for Laeger
|
November 11, 1974
[The concentrations of arsenic, manganese and selenium in organs from normal and uremic persons determined by activation analysis]
N A Larsen, B Nielsen, H Pakkenberg, et al.
Neurotoxicology and Teratology
|
April 7, 1999
MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study
M Mikkelsen, A Møller, L H Jensen, et al.
The New England Journal of Medicine
|
May 30, 1985
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
R S Burns, P A LeWitt, M H Ebert, et al.
Journal of Neuroscience Methods
|
February 1, 1990
An efficient method for estimating the total number of neurons in rat brain cortex
L Korbo, B Pakkenberg, O Ladefoged, et al.
Acta Neurologica Scandinavica
|
January 1, 1974
RNA treatment of dementia. A double-blind study
S Munch-Petersen, H Pakkenberg, H Kornerup, et al.
Page
of 8